Standout Papers

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease 2012 2026 2016 2021 1.0k
  1. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (2012)
    Vicente E. Torres, Arlene B. Chapman et al. New England Journal of Medicine
  2. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease (2017)
    Vicente E. Torres, Arlene B. Chapman et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 101 standout
Sub-graph 1 of 18

Citing Papers

Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Acute Kidney Injury in Patients with Cirrhosis
2023 Standout
7 intermediate papers

Works of John Ouyang being referenced

Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database
2015
Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia
2010
and 4 more

Author Peers

Author Last Decade Papers Cites
John Ouyang 2119 1911 1984 67 4.7k
Frank S. Czerwiec 2571 2283 2412 63 5.4k
Myriam Fornage 1288 597 1427 172 6.0k
Bengt‐Åke Bengtsson 1102 634 1198 101 7.0k
Svend Strandgaard 513 1110 617 136 5.8k
Jianning Zhang 904 607 1839 184 6.0k
Kerstin Landin‐Wilhelmsen 1370 481 1192 127 5.6k
Fausto Santeusanio 1407 269 1251 173 7.7k
C. Jacquot 250 1349 995 152 5.5k
Martin Konrad 578 1030 2906 96 6.1k
Harald Dobnig 491 395 1636 88 6.5k

All Works

Loading papers...

Rankless by CCL
2026